ArticleThe Journal of clinical endocrinology and metabolism2020

Invited Commentary: A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.

Phyllis W SpeiserPubMed ↗Publisher ↗

No numbers read from the abstract.